IVBIY (IVBIY PINK) stock market data APIs
$45.4157
0(0%)
as of July 3, 2025
Try our APIs with
free plan!
IVBIY Financial Data Overview
Price chart is built with
Anychart
Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverematinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), Dupert (fulzerasib), DOVBLERON (taletrectinib), Jaypirca (pirtobrutinib), limertinib, and SYCUME (teprotumumab N01 injection). The company is also developing three new drugs, which are under regulatory review; four assets in Phase 3 and pivotal clinical trials; and 15 molecules in early clinical stage. In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People's Republic of China.
Prev. Close
45.4157
Open
45.4157
High
45.6904
Low
45.4157
52 wk Range
19.15-45.72
Market Cap
18 724 M
Shares Outstanding
410 M
Revenue
9 422 M
Beta
0.227
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get IVBIY data using free add-ons & libraries
Get IVBIY Fundamental Data
IVBIY Fundamental data includes:
- Net Revenue: 9 422 M
- EBITDA: 23 990 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
IVBIY News
New
3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 47.8%
As global markets continue to navigate trade negotiations and economic shifts, investors are increasingly turning their attention to Asia, where opportunities may be emerging amidst the volatility. Id...
How mazdutide compares against weight loss therapies from Novo Nordisk, Lilly
[Ozempic Insulin injection pen] CR/iStock via Getty Images With the recent approval in China of Innovent Biologics' (OTCPK:IVBIY [https://seekingalpha.com/symbol/IVBIY]) mazdutide as the first-ever d...
Novo Nordisk, Eli Lilly face first major obesity drug rival in China as Innovent gains approval for mazdutide
[Syringes, injection bottles and tablets lying on the table] Sviatlana Barchan/iStock via Getty Images Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]) and Eli Lilly & Co. (NYSE:LLY [https://...
Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms
SAN FRANCISCO and SUZHOU, China, June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commerciali...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
